| |
Excellent outcomes and clinically proven
Preliminary results from a multi-center European clinical study on the Invent ZO as well as a marketing study conducted in France on the XL Stabi ZO will be presented at the Carl Zeiss Innovation Symposium in Stockholm during the ESCRS congress. The marketing study conducted in France on the XL Stabi ZO confirms through MTF measurements (Z4.0) the excellent outcomes provided by the ZO aspheric optic. | |
|